Article
http://www.researchprotection.org/sharavTestimonyArmyMedDept020507.htm has moved to:
https://ahrp.org/testimonypresentations/armymeddept.php
Please click on the link above to visit this page, and adjust your bookmarks accordingly.
Similar Posts
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and The New York Times focus on the Vioxx fall out–a case that encapsulates the corrupt practices in drug research. Merck and FDA officials intervened to conceal the lethal cardiac effect of Vioxx. Mother…
Mentally disabled research subjects ‘need protection’ — Nature
October 16, 1997 NATURE Mentally disabled research subjects ‘need protection’ by Meredith Wadman p. 652 [Washington] When the US National Bioethics Advisory Commission (NBAC) convenes again on Sunday (19 October), it will wrestle with a difficult matter on which it is due to report by January. The commission’s human subjects…
Asthma Drug trial Halted -Health Risk Are Suspected
Asthma Drug trial Halted -Health Risk Are Suspected Mon, 17 Mar 2003 A spate of recent articles have shown that pharmaceutical companies suppress the publication of negative findings about their products. However, that is not the only way these companies keep physicians and patients uninformed about adverse drug effects. Another…
Serono to pay $704 million for Illegal Marketing AIDS drug and "voodoolike" clinical trials – NYT
Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…
GAO Found CDC Supervision of Bioagents Weak
GAO Found CDC Supervision of Bioagents Weak Wed, 4 Dec 2002 The Scientist reports that on Nov. 22, the General Accounting Office (GAO) sent a letter to Secretary of Health and Human Services reporting that its auditors spotted “significant management weaknesses” in the Centers for Disease Control and Prevention (CDC)…
High Mortality Rates in Clinical Trials
High Mortality Rates in Clinical Trials Mon, 4 Nov 2002 Serious concerns are being raised about the high death rate in clinical trials. According to several articles in the American Journal of Respiratory and Critical Care Medicine, the lives of critically ill patients have been put at increased risk due…